This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 956314.
|
Jointly organized with the Swiss Chemical Society, Division for Medicinal Chemistry & Chemical Biology (DMCCB)
International Organizing Committee Chairs: Dr Yves P. AUBERSON, Novartis Institutes for Biomedical Research, Basel, Switzerland, Prof. Maja KOEHN, University of Freiburg, Freiburg, Germany Members: Prof. Yimon AYE, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland, Prof. Dennis GILLINGHAM, University of Basel, Basel, Switzerland, Prof. Gianluca SBARDELLA, University of Salerno, Fisciano, Italy International Scientific Committee Members: Prof. Marko ANDERLUH, University of Ljubljana, Ljubljana, Slovenia, Prof. Gonçalo BERNARDES, University of Cambridge, Cambridge, United Kingdom, Dr Sebastian ESSIG, Bayer AG, Wuppertal, Germany, Dr Anna-Lena GUSTAVSSON, Karolinska Institutet, Solna, Sweden, Prof. Christian HEINIS, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland, Prof. Zaneta NIKOLOVSKA-COLESKA, University of Michigan, Ann Arbor, United States, Prof. Christian A. OLSEN, University of Copenhagen, Copenhagen, Denmark, Dr Arne RUFER, F. Hoffmann-La Roche Ltd., Basel, Switzerland, Dr Ulrich SCHOPFER, Novartis Institutes for BioMedical Research, Basel, Switzerland, Dr Mario VAN DER STELT, Leiden University, Leiden, The Netherlands, Dr Andrew ZHANG, AstraZeneca, Waltham, United States Date: 16-18 November 2023 Venue: Basel, Switzerland Registration: opens in February 2023
0 Comments
Leave a Reply. |
Archives
November 2024
|